Journal article

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study

Maria Luisa Montes, Mark Nelson, Pierre-Marie Girard, Joe Sasadeusz, Andrzej Horban, Beatriz Grinsztejn, Natalia Zakharova, Antonio Rivero, Jacques Durant, Enrique Ortega-Gonzalez, Erkki Lathouwers, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, James Witek, Juan Gonzalez-Garcia

Journal of Antimicrobial Chemotherapy | OXFORD UNIV PRESS | Published : 2016

DOI: 10.1093/jac/dkv323

University of Melbourne Researchers

Grants

Funding Acknowledgements

This work was supported by Janssen Pharmaceuticals. In addition, the editorial support (see below) was funded by Janssen Pharmaceuticals.

Citation metrics

2Web of Science
2Scopus

Keywords

Pharmacokinetics
Drug-Interactions
Middle Aged
Hiv Infections
Polyethylene Glycols
Antiviral Agents
Life Sciences & Biomedicine
Ribavirin
Alpha-2a Plus Ribavirin
Science & Technology
Treatment Outcome
Coinfection
Drug-Related Side Effects and Adverse Reactions
Infectious Diseases
Female
Adolescent
Male
Management
Randomized-Trial
Humans
Young Adult
Genotype 1 Infection
Microbiology
Aged
Interferon-Alpha-2b
Oligopeptides
Pharmacology & Pharmacy
Recombinant Proteins
Interferon-Alpha
Hepatitis C, Chronic
Adult